NEXGEL, Inc. (NXGL) Discusses Strategic Platform Reorganization and Refocus on Medical Device and Biomedical Innovation TranscriptSeeking Alpha · Sep 24, 2026
NEXGEL Announces Dial-In Details for Investor Update CallGlobeNewsWire · Sep 23, 2026
NEXGEL Announces Date for Investor Update CallGlobeNewsWire · Sep 16, 2026
NEXGEL ANNOUNCES LEADERSHIP TRANSITION AND STRATEGIC REVIEW INITIATIVEGlobe News Wire · Aug 20, 2026
NEXGEL Reports Second Quarter 2026 Financial ResultsGlobeNewsWire · Aug 17, 2026NEXGEL, Inc. is a company that develops and produces advanced hydrogels and gels. These materials are characterized by their significant water content, aqueous polymer composition, and electron beam cross-linking technology. NEXGEL's diverse product range serves crucial applications across several sectors, including wound care management, medical diagnostic tools, transdermal drug delivery systems, and cosmetic formulations.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 14, 2026 | -$2.40 | -$8.00 | Miss |
| May 13, 2026 | -$1.40 | -$2.20 | Miss |
| Mar 31, 2026 | -$1.80 | -$0.11 | Beat |
| Nov 12, 2025 | -$1.60 | -$0.08 | Beat |
| Aug 12, 2025 | -$0.20 | -$0.09 | Beat |
| May 13, 2025 | -$1.40 | -$0.09 | Beat |